Clinical Laserthermia Systems AB (CLS B):企業の製品パイプライン分析2018

◆英語タイトル:Clinical Laserthermia Systems AB (CLS B) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12756
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company’s flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a precise and safe treatment. It also comprises a laser applicator with introducer that is used for positioning of the fiber, depending on the tumor size. TRANBERG is developed for immune stimulating interstitial thermotherapy (imILT). CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its products to hospitals and clinics. CLS is headquartered Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Clinical Laserthermia Systems AB Company Overview 5
Clinical Laserthermia Systems AB Company Snapshot 5
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview 5
Clinical Laserthermia Systems AB – Pipeline Analysis Overview 8
Business Description 8
Clinical Laserthermia Systems AB – Key Facts 8
Clinical Laserthermia Systems AB – Major Products and Services 9
Clinical Laserthermia Systems AB Pipeline Products by Development Stage 10
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14
Clinical Laserthermia Systems AB Pipeline Products Overview 16
CLS Cancer Immunotherapy System – Prostate Cancer 16
CLS Cancer Immunotherapy System – Prostate Cancer Product Overview 16
CLS Cancer Immunotherapy System – Prostate Cancer Clinical Trial 17
imILT Software 18
imILT Software Product Overview 18
imILT Software Clinical Trial 19
TRANBERG Cancer Immunotherapy System – Breast Cancer 20
TRANBERG Cancer Immunotherapy System – Breast Cancer Product Overview 20
TRANBERG Cancer Immunotherapy System – Breast Cancer Clinical Trial 21
TRANBERG Cancer Immunotherapy System – Pancreatic Cancer 22
TRANBERG Cancer Immunotherapy System – Pancreatic Cancer Product Overview 22
TRANBERG Cancer Immunotherapy System – Pancreatic Cancer Clinical Trial 23
TRANBERG Cancer Immunotherapy System – Skin Cancer 24
TRANBERG Cancer Immunotherapy System – Skin Cancer Product Overview 24
TRANBERG Cancer Immunotherapy System – Solid Cancers 25
TRANBERG Cancer Immunotherapy System – Solid Cancers Product Overview 25
TRANBERG Cancer Immunotherapy System – Solid Cancers Clinical Trial 26
Clinical Laserthermia Systems AB – Key Competitors 27
Clinical Laserthermia Systems AB – Key Employees 28
Clinical Laserthermia Systems AB – Key Employee Biographies 29
Clinical Laserthermia Systems AB – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Clinical Laserthermia Systems AB, Recent Developments 31
Jun 18, 2018: CLS receives new order for single use products from UTMB in the U.S., for treatment of early stage prostate cancer 31
Apr 19, 2018: First patients treated with CLS TRANBERG-system in the clinical study at Toronto General Hospital, Canada 31
Apr 19, 2018: CLS participates with hands-on workshop at the European Conference on Interventional Oncology 31
Apr 17, 2018: Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer 32
Apr 11, 2018: Clinical Laserthermia Systems Exhibits MRI-Guided Laser Ablation System at Southwest Prostate Cancer Symposium 32
Apr 04, 2018: CLS quality processes received good marks by American authority FDA 32
Mar 16, 2018: CLS and Toronto General Hospital, Canada, carry out clinical study regarding MRI guided FLA treatment of prostate cancer 33
Mar 14, 2018: CLS receives new order for the TRANBERG-system from UTMB in the U.S. 33
Mar 08, 2018: CLS imILT treatment of pancreatic cancer shows positive trend regarding survival 33
Jan 02, 2018: CLS single use accessories evaluated by Laser Prostate Centers of America 34
Appendix 35
Methodology 35
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview 5
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type 6
Clinical Laserthermia Systems AB Pipeline Products by Indication 7
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 7
Clinical Laserthermia Systems AB, Key Facts 8
Clinical Laserthermia Systems AB, Major Products and Services 9
Clinical Laserthermia Systems AB Number of Pipeline Products by Development Stage 10
Clinical Laserthermia Systems AB Pipeline Products Summary by Development Stage 11
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14
Clinical Laserthermia Systems AB Ongoing Clinical Trials Summary 15
CLS Cancer Immunotherapy System - Prostate Cancer - Product Status 16
CLS Cancer Immunotherapy System - Prostate Cancer - Product Description 16
CLS Cancer Immunotherapy System - Prostate Cancer - Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma 17
CLS Cancer Immunotherapy System - Prostate Cancer - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study 17
imILT Software - Product Status 18
imILT Software - Product Description 18
imILT Software - Immunostimulating Interstitial Laser Thermotherapy in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study 19
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Status 20
TRANBERG Cancer Immunotherapy System - Breast Cancer - Product Description 20
TRANBERG Cancer Immunotherapy System - Breast Cancer - Interstitial Laser Thermotherapy (imILT) as a Treatment option in Breast Cancer Patients not suitable for Surgical Excision 21
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Status 22
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Description 22
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - An Open-label, Comparative Trial to Evaluate the Effect of imILT in Patients with Advanced Disease or Stage IV Pancreatic Carcinoma 23
TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Prospective, Open, Non Comparative Trial to Evaluate Safety and Feasibility of Immunostimulating Interstitial Laser Thermotherapy (imILT) in Stage III Pancreatic Carcinoma 23
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Status 24
TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Description 24
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Status 25
TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Description 25
TRANBERG Cancer Immunotherapy System - Solid Cancers - To Evaluate the Safety and Palliative Treatment Effect on Patients with Solid Cancers by Immunostimulating Interstitial Laser Thermotherapy (imILT) 26
Clinical Laserthermia Systems AB, Key Employees 28
Clinical Laserthermia Systems AB, Key Employee Biographies 29
Clinical Laserthermia Systems AB, Subsidiaries 30
Glossary 37

List of Figures
Clinical Laserthermia Systems AB Pipeline Products by Equipment Type 6
Clinical Laserthermia Systems AB Pipeline Products by Development Stage 10
Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14

★海外企業調査レポート[Clinical Laserthermia Systems AB (CLS B):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virgin Group Ltd.:企業のM&A・提携・投資分析
    Virgin Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Mallinckrodt LLC:医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation i …
  • Michels Corp:企業の戦略・SWOT・財務情報
    Michels Corp - Strategy, SWOT and Corporate Finance Report Summary Michels Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析
    Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Deltex Medical Group plc (DEMG):企業の財務及び戦略的SWOT分析
    Summary Deltex Medical Group plc (Deltex Medical) is a medical device manufacturer that manufactures fluid management equipment and oesophageal doppler monitoring system. The company offers products that include CardioQ-ODM+, probes, simulator, and bougies. It provides probes that include surgical p …
  • IGI Insurance Limited:企業の戦略・SWOT・財務分析
    SummaryIGI Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Riverbed Technology, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Riverbed Technology, Inc. Merge …
  • Minesto AB (MINEST):電力:M&Aディール及び事業提携情報
    Summary Minesto AB (Minesto) is a marine energy technology developer. The company offers ervices such as renewable energy solutions, tidal power plants operations and management, power generation, and deep green technology solutions. It also provides control-system design, hydrodynamics, simulation, …
  • NCI, Inc. (NCIT):企業概要、財務及び戦略的SWOT分析
    Summary NCI, INC. (NCI) is an information technology (IT) company. The company provides engineering, logistics, and professional services and solutions, program management, acquisition and lifecycle support. It offers enterprise systems management services such as infrastructure operations and manag …
  • SeouLin Bioscience Co., Ltd. (038070):企業の戦略的SWOT分析
    Summary SeouLin Bioscience Co., Ltd. (SLB) is a biotechnology company that develops bio pharmaceuticals. The company’s product VisuFect 100 Gene Delivery Reagent is made up of organic compound and chemically modified cells without a transfection reagent. Its reagent is used for transfection of vario …
  • deCODE genetics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' deCODE genetics, Inc. Mergers a …
  • The Medicines Company (MDCO):医療機器:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Decathlon S.A.:企業のM&A・提携・投資分析
    Decathlon S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Decathlon S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • ZIOPHARM Oncology Inc (ZIOP):企業財務及び戦略的SWOT分析
    Summary ZIOPHARM Oncology Inc (ZIOPHARM), formerly EasyWeb, Inc. is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to deliver safe, effective and scalable cell-based therapies for the treatment of cancer …
  • InterGen N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' InterGen N.V. Mergers and Acqui …
  • Spinal Kinetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Kinetics Inc (SKG) is a medical device company that develops motion preservation systems for treating degenerative diseases of the spine. The company provides products such as M6-C artificial cervical disc and M6-L artificial lumbar disc. The M6 artificial cervical disc offers an opti …
  • The Boeing Company (BA)(エネルギー分野):企業M&A動向
    Summary The Boeing Company (Boeing) is an aerospace company. It is one of the leading manufacturers of commercial jetliners and space, defense and security systems. Boeing’s products and services include commercial and military aircraft; weapons, satellites, electronic and defense systems; launch sy …
  • Valad Property Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Valad Property Group Mergers an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆